Terms: = Breast cancer AND SF3B1, ENSG00000115524, 23451, O75533, SF3b155, SAP155, PRPF10, PRP10
30 results:
1. Association of Germline Variation in Driver Genes with breast cancer Risk in Chilean Population.
Morales-Pison S; Tapia JC; Morales-González S; Maldonado E; Acuña M; Calaf GM; Jara L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003265
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
3. sf3b1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response.
Bland P; Saville H; Wai PT; Curnow L; Muirhead G; Nieminuszczy J; Ravindran N; John MB; Hedayat S; Barker HE; Wright J; Yu L; Mavrommati I; Read A; Peck B; Allen M; Gazinska P; Pemberton HN; Gulati A; Nash S; Noor F; Guppy N; Roxanis I; Pratt G; Oldreive C; Stankovic T; Barlow S; Kalirai H; Coupland SE; Broderick R; Alsafadi S; Houy A; Stern MH; Pettit S; Choudhary JS; Haider S; Niedzwiedz W; Lord CJ; Natrajan R
Nat Genet; 2023 Aug; 55(8):1311-1323. PubMed ID: 37524790
[TBL] [Abstract] [Full Text] [Related]
4. breast metastatic tumors in lung can be substituted by lung-derived malignant cells transformed by alternative splicing H19 lncRNA.
Xu JB; Cao J; Xia J; Zhu Y; He Y; Cao MG; Fang BM; Thiery JP; Zhou W
Breast Cancer Res; 2023 May; 25(1):59. PubMed ID: 37254190
[TBL] [Abstract] [Full Text] [Related]
5. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract] [Full Text] [Related]
6. Studying the connection between sf3b1 and four types of cancer by analyzing networks constructed based on published research.
Samy A; Ozdemir MK; Alhajj R
Sci Rep; 2023 Feb; 13(1):2704. PubMed ID: 36792691
[TBL] [Abstract] [Full Text] [Related]
7. Heritable genomic diversity in breast cancer driver genes and associations with risk in a Chilean population.
Morales-Pison S; Gonzalez-Hormazabal P; Tapia JC; Salas-Burgos A; Ampuero S; Gómez F; Waugh E; Reyes JM; Jara L
Biol Res; 2022 May; 55(1):20. PubMed ID: 35637532
[TBL] [Abstract] [Full Text] [Related]
8. Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells.
North K; Benbarche S; Liu B; Pangallo J; Chen S; Stahl M; Bewersdorf JP; Stanley RF; Erickson C; Cho H; Pineda JMB; Thomas JD; Polaski JT; Belleville AE; Gabel AM; Udy DB; Humbert O; Kiem HP; Abdel-Wahab O; Bradley RK
Nat Biotechnol; 2022 Jul; 40(7):1103-1113. PubMed ID: 35241838
[TBL] [Abstract] [Full Text] [Related]
9. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
10. Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
Callens C; Driouch K; Boulai A; Tariq Z; Comte A; Berger F; Belin L; Bièche I; Servois V; Legoix P; Bernard V; Baulande S; Chemlali W; Bidard FC; Fourchotte V; Salomon AV; Brain E; Lidereau R; Bachelot T; Saghatchian M; Campone M; Giacchetti S; Zafrani BS; Cottu P
Genome Med; 2021 Mar; 13(1):44. PubMed ID: 33722295
[TBL] [Abstract] [Full Text] [Related]
11. Mutant sf3b1 promotes AKT- and NF-κB-driven mammary tumorigenesis.
Liu B; Liu Z; Chen S; Ki M; Erickson C; Reis-Filho JS; Durham BH; Chang Q; de Stanchina E; Sun Y; Rabadan R; Abdel-Wahab O; Chandarlapaty S
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33031100
[TBL] [Abstract] [Full Text] [Related]
12. Puncta intended: connecting the dots between autophagy and cell stress networks.
Ho CJ; Samarasekera G; Rothe K; Xu J; Yang KC; Leung E; Chan M; Jiang X; Gorski SM
Autophagy; 2021 Apr; 17(4):1028-1033. PubMed ID: 32507070
[TBL] [Abstract] [Full Text] [Related]
13. Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast.
Sun P; Zhong Z; Lu Q; Li M; Chao X; Chen D; Hu W; Luo R; He J
Mod Pathol; 2020 Oct; 33(10):1945-1960. PubMed ID: 32358590
[TBL] [Abstract] [Full Text] [Related]
14. Knockdown of sf3b1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract] [Full Text] [Related]
15. Hotspot sf3b1 mutations induce metabolic reprogramming and vulnerability to serine deprivation.
Dalton WB; Helmenstine E; Walsh N; Gondek LP; Kelkar DS; Read A; Natrajan R; Christenson ES; Roman B; Das S; Zhao L; Leone RD; Shinn D; Groginski T; Madugundu AK; Patil A; Zabransky DJ; Medford A; Lee J; Cole AJ; Rosen M; Thakar M; Ambinder A; Donaldson J; DeZern AE; Cravero K; Chu D; Madero-Marroquin R; Pandey A; Hurley PJ; Lauring J; Park BH
J Clin Invest; 2019 Aug; 129(11):4708-4723. PubMed ID: 31393856
[TBL] [Abstract] [Full Text] [Related]
16. Mutational Diversity and Therapy Response in breast cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial.
Loibl S; Treue D; Budczies J; Weber K; Stenzinger A; Schmitt WD; Weichert W; Jank P; Furlanetto J; Klauschen F; Karn T; Pfarr N; von Minckwitz G; Möbs M; Jackisch C; Sers C; Schneeweiss A; Fasching PA; Schem C; Hummel M; van Mackelenbergh M; Nekljudova V; Untch M; Denkert C
Clin Cancer Res; 2019 Jul; 25(13):3986-3995. PubMed ID: 30979740
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
Kahles A; Lehmann KV; Toussaint NC; Hüser M; Stark SG; Sachsenberg T; Stegle O; Kohlbacher O; Sander C; ; Rätsch G
Cancer Cell; 2018 Aug; 34(2):211-224.e6. PubMed ID: 30078747
[TBL] [Abstract] [Full Text] [Related]
18. Mutational landscape of RNA-binding proteins in human cancers.
Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
[TBL] [Abstract] [Full Text] [Related]
19. Uncommon somatic mutations in metastatic NUT midline carcinoma.
Cavalieri S; Stathis A; Fabbri A; Sonzogni A; Perrone F; Tamborini E; Pelosi G; de Braud F; Platania M
Tumori; 2017 Nov; 103(Suppl. 1):e5-e8. PubMed ID: 28967088
[TBL] [Abstract] [Full Text] [Related]
20. Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (sf3b1).
Chung FF; Tan PF; Raja VJ; Tan BS; Lim KH; Kam TS; Hii LW; Tan SH; See SJ; Tan YF; Wong LZ; Yam WK; Mai CW; Bradshaw TD; Leong CO
Sci Rep; 2017 Feb; 7():42504. PubMed ID: 28198434
[TBL] [Abstract] [Full Text] [Related]
[Next]